Cirrhosis Due to Hepatitis B Clinical Trial
Official title:
A Randomised Trial Comparing Entacavir and Tenofovir in Patients With HBV Decompensated Cirrhosis
Entacavir and tenofovir are two first line therapies for chronic hepatitis B. Both agents have been claimed equivalent in treatment, there are no head to head trials available in the literature about there effectiveness in HBV Decompensated Cirrhosis. The investigators aimed to compare safety/efficacy and virological response in patients with HBV Decompensated Cirrhosis.
The effectiveness of entacavir and tenofovir has not been prospectively studied in HBV Decompensated cirrhosis? This prospective, randomised clinical trial will help us in better patient management more efficacy and cost effectiveness. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05832229 -
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
|
Phase 2 | |
| Recruiting |
NCT05740358 -
Liver Cirrhosis Network Cohort Study
|
||
| Not yet recruiting |
NCT04543643 -
Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in Cirrhosis
|
Phase 3 | |
| Recruiting |
NCT05507762 -
Study of Human Umbilical Cord Mesenchymal Stem Cell in Patients With Cirrhosis Due to Hepatitis B (Compensation Stage)
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04501224 -
The Efficacy and Safety of TAF vs Other NAs in Patients With LVL
|
N/A |